Join
Live feed
·
INSIDERFilingvia Quantisnow
Kezar Life Sciences Inc. logo

Chief Operating Officer Schiller Mark C. sold $2,401 worth of shares (561 units at $4.28), decreasing direct ownership by 17% to 2,739 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KZR· Kezar Life Sciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KZR (Kezar Life Sciences Inc.) and more on Quantisnow.